Celldex Therapeutics News

Celldex Therapeutics Analyst Ratings

BenzingaJun 12 02:09

Wolfe Research Initiates Coverage on Celldex Therapeutics With Outperform Rating, $51 Price Target

MT NewswiresJun 11 19:28

Celldex Therapeutics Analyst Ratings

BenzingaJun 3 19:05

Celldex Therapeutics Analyst Ratings

BenzingaMay 15 22:39

HC Wainwright & Co. : The Celldex Therapeutics (CLDX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $80.00.

Zhitong FinanceMay 15 22:40

Celldex Therapeutics Analyst Ratings

BenzingaMay 7 18:53

HC Wainwright & Co. Reiterates Buy on Celldex Therapeutics, Maintains $80 Price Target

BenzingaMay 7 18:55

Celldex Therapeutics Analyst Ratings

BenzingaApr 17 22:34

HC Wainwright & Co. : The Celldex Therapeutics (CLDX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $80.00.

Zhitong FinanceApr 17 22:40

Celldex Therapeutics Analyst Ratings

BenzingaMar 23 01:50

Cantor Fitzgerald Reiterates Overweight on Celldex Therapeutics, Maintains $67 Price Target

BenzingaMar 23 01:51

Guggenheim Maintains Buy on Celldex Therapeutics, Raises Price Target to $90

BenzingaFeb 28 01:04

Celldex Therapeutics Analyst Ratings

BenzingaFeb 28 01:03

Celldex Therapeutics Analyst Ratings

BenzingaDec 20, 2023 21:32

Wells Fargo Upgrades Celldex Therapeutics to Equal-Weight, Announces $27 Price Target

BenzingaNov 10, 2023 19:27

Celldex Therapeutics Analyst Ratings

BenzingaNov 10, 2023 19:25

HC Wainwright & Co. Maintains Buy on Celldex Therapeutics, Raises Price Target to $80

BenzingaNov 7, 2023 00:09

Celldex Therapeutics Analyst Ratings

BenzingaNov 7, 2023 00:07

Celldex (CLDX) Gets a Buy From Cantor Fitzgerald

TipRanksNov 6, 2023 21:01

Cantor Fitzgerald Maintains Overweight on Celldex Therapeutics, Lowers Price Target to $52

BenzingaNov 4, 2023 00:49